AVIR vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

AVIR

65.4
AI Score
VS
AVIR Wins

JBIO

50.1
AI Score

Investment Advisor Scores

AVIR

65score
Recommendation
BUY

JBIO

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AVIR JBIO Winner
Net Income 121.00M -96.13M AVIR
Operating Income 138.38M -102.36M AVIR
ROE 17.0% -21.9% AVIR
ROA 15.7% -20.4% AVIR
Total Assets 772.89M 472.11M AVIR
Cash 764.38M 107.25M AVIR
Current Ratio 13.58 14.93 JBIO
Free Cash Flow -87.01M -67.93M JBIO

Relative Price Performance (Last 90 Days)

AVIR 1M: -27.7% · 3M: -14.1% JBIO 1M: -9.7% · 3M: -22.9%

Current Technical Phase

AVIR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 25

RSI (14): 25.0 · Price: $4.08

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.5 · Price: $15.13

Fundamentals Snapshot

Metric AVIR JBIO
Market Cap — —
Forward P/E -2.8 -5.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 3.0% 0.0%
Gross Margin -0.8% —
Operating Margin 0.0% 0.0%
EPS -2.13 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AVIR is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.